GlassScriptPhysician profile
Matthew W Schaeffer
NPI 1013956507
$5,260.08
in general payments reported to CMS, 2019-2025
13 companies · $216 in 2025
The $216 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.12 · 2020: $3,985 · 2021: $81.13 · 2022: $43.00 · 2023: $18.24 · 2024: $905 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $800 · Travel and Lodging: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $800.17 |
| Travel and Lodging | $338.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,152.12 | 2020 | |
| Liberty Surgical INC. | $1,832.78 | 2020 | |
| Boston Scientific Corporation | $968.81 | 2024-2025 | Intracept |
| Scilex Pharmaceuticals INC. | $49.16 | 2021 | |
| Stryker Corporation | $49.09 | 2025 | Spinejack, Mild Device Kit |
| Appliedvr INC | $48.18 | 2025 | Relievrx |
| Vertex Pharmaceuticals Incorporated | $38.05 | 2025 | |
| Foundation Fusion Solutions, LLC | $31.97 | 2021 | |
| Depuy Synthes Sales INC. | $30.01 | 2022 | |
| Si-Bone, INC. | $18.24 | 2023 | |
| Solventum Corporation | $16.56 | 2024 | Prevena, V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice |
| Johnson & Johnson Surgical Vision, INC. | $12.99 | 2022 | |
| Electronic Waveform Lab, INC. | $12.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Schaeffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.